<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Breast cancer is the most common cancer in women and represents a global health burden both in the developed and developing countries. Hong et al. study apigenin and luteolin to better understand their mechanism of action in the context of breast cancer intravasation of the lymphatic barrier. Both of these natural compounds were evaluated in a three-dimensional assay system containing MDA-MB231 breast cancer spheroids and immortalized lymph endothelial cell monolayers (
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2018.00220" class="ext-link" xmlns:xlink="http://www.w3.org/1999/xlink">Hong et al.</ext-link>)
</p>
